Valar Ventures Llc — 2025 Investments
6 investments dated 2025 · listed companies and verified rows first · show all
Octane offers financing for recreational and powersports vehicles such as motorcycles, ATVs, and mowers, letting consumers check their rate with a soft credit pull.
ConsumerFintechMarketplacesNew York, US
Jason Guss(Executive Officer, Director)inMark Davidson(Executive Officer)inMaria Aveledo(Executive Officer)inMark Molnar(Executive Officer)inMurali Vajjiravel(Executive Officer)inSean Fernandez-Ledon(Executive Officer)in
Board seatJames Fitzgerald· per SEC Form D
Co-investorsBlank Space VenturesChaos VenturesContour Venture PartnersDreamit VenturesFundersClubGaingels+6 more
Gaia offers fixed-price IVF and fertility treatment plans in the U.S., bundling costs into one price with monthly payment options, unlimited embryo transfers, and guaranteed minimum egg counts.
Digital HealthFemTechFintech
Nader AlSalim(Founder)in
Co-investorsClocktower VenturesFJ LabsHeliad AGKindred CapitalOptum Ventures
Gaia provides cryptocurrency solutions for listed companies, corporations, and institutional investors, including risk-controlled Bitcoin treasury strategies, lending products, DeFi index construction and operation, and crypto-to-fiat payment integration for physical and online stores.
AI & Machine LearningCrypto & Web3Fintech
Co-investorsNOW JapanSEEDRA VenturesVenture Labo Investment
Panacea Financial is a digital bank for doctors, dentists, and veterinarians that offers loans, banking, payments, and contract insights tailored to the stages of a medical career from training through retirement.
FintechHealthtechLittle Rock, US
Tyler Stafford(Chief Executive Officer & Co-Founder)inMichael Jerkins(President & Co-Founder)inNed Palmer(COO & Co-Founder)inBrandon Finazzo(Chief Growth Officer)Will McCandless(Chief Financial Officer)Anna Khayet(Chief Marketing Officer)
Co-investorsHoxton Ventures
Panacea-ml provides clinical development data analytics to pharmaceutical companies and contract research organizations, helping them design and conduct clinical trials more efficiently by identifying optimal trial participants and predicting adverse outcomes.
AI & Machine LearningBiotechHealthtech
Boaz Lerner(Founder)in
Co-investorsSanara Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.










__Twitter.png)














